香港股市 已收市

Journey Medical Corporation (DERM)

NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
加入追蹤清單
4.9800+0.0500 (+1.01%)
收市:04:00PM EDT

Journey Medical Corporation

9237 East Via de Ventura Boulevard
Suite 105
Scottsdale, AZ 85258
United States
480 434 6670
https://journeymedicalcorp.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工41

高階主管

名稱頭銜支付行使價出生年份
Dr. Lindsay Allan RosenwaldExecutive Chairman50k1955
Mr. Claude MaraouiFounder, President, CEO & Director934.45k1967
Mr. Joseph M. BeneschCFO & Corporate Controller409.04k1967
Mr. Andrew J. ZwibleVice President of Operations
Mr. Ramsey AlloushGeneral Counsel & Company Secretary1986
Mr. Robert NevinChief Commercial Officer1968
Jaclyn JaffeSenior Director of Corporate Operations
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

公司管治

截至 無 止,Journey Medical Corporation 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。